Certara to Participate in Upcoming Investor Conferences Press Release Certara to Participate in Upcoming Investor Conferences RADNOR, PA – September 2, 2025 -- Certara, Inc. (Nasdaq: CERT), a global leader in…Danielle PillsburySeptember 2, 2025
Designing a High-Value Drug Development Program: From Concept to First-in-Human (FIH) Webinar Designing a High-Value Drug Development Program: From Concept to First-in-Human (FIH) Danielle PillsburyAugust 29, 2025
Streamline Table Creation with AI-Specialized for Regulatory Writers Webinar Streamline Table Creation with AI-Specialized for Regulatory Writers CertaraAugust 27, 2025
Certara Integral: The Master Data Repository Powering Efficient and Collaborative PK/PD Workflows On-Demand Webinar Certara Integral: The Master Data Repository Powering Efficient and Collaborative PK/PD Workflows Charles River improved its global pharmacokinetics workflows by adopting Certara’s Integral as a central data…CertaraAugust 27, 2025
Certara Releases Environmental, Social and Governance Report Announcement Certara Releases Environmental, Social and Governance Report The report highlights a commitment to sustainability and corporate responsibilities. RADNOR, Pa. – August 26,…CertaraAugust 26, 2025
Top 5 Recommendations for Successful Interactive Value Messaging Blog Top 5 Recommendations for Successful Interactive Value Messaging August 22, 2025 Over the past two decades in health economics and market access, I’ve…CertaraAugust 22, 2025
Blueprint for Biotech Success: De-risking Early Development to Secure Long-Term Value Webinar Blueprint for Biotech Success: De-risking Early Development to Secure Long-Term Value CertaraAugust 21, 2025
ToxStudio®: In silico tools to accelerate toxicology assessments Webinar ToxStudio®: In silico tools to accelerate toxicology assessments CertaraAugust 19, 2025
Certara IQ: The Scalable AI-Powered QSP Software Webinar Certara IQ: The Scalable AI-Powered QSP Software CertaraAugust 19, 2025